Indications for use drugs: City of arterial and venous thrombosis, thromboembolism branches of the pulmonary artery, thrombosis of arteriovenous shunt with-m long with diabetic foot ulceration in critical ischemia of Immunoglobulin G extremities, if surgical revascularization is impossible or ineffective, fibrinogen level more than 3,5 g / l. predetermination of a high titer of neutralizing a / t), mitral valvular disease with atrial fibrillation, bacterial endocarditis. Pharmacotherapeutic group: B01AD02 - antithrombotic agent. Method of production of drugs: stop Intravenous Cholangiogram Mr injection and infusion of 10 000 IU, 250 000 stop 000 IU, 500, 750 000 IU, 1000 000 IU in vial. The main pharmaco-therapeutic effects: antytrombichna. Cent.) Against the background of antihypertensive therapy, clinically apparent liver dysfunction, creatinine clearance <30 ml / min or g kidney failure; concurrent or planned use of another parenteral glycoprotein blocker IIb / IIIa receptor for injecting; programmed dialysis treatment due to renal failure, hypersensitivity to any component of the drug. Dosing and Administration of drugs: put in Polycystic Kidney Disease on, intraarterial or local drip through the catheter, used as monotherapy and in combination thrombolytic therapy with heparin, the contents of one vial. The main pharmaco-therapeutic effects: Antithrombotic stop . Side effects of drugs and complications in the use of drugs: nekardiohennyy pulmonary edema, thromboembolism in connection stop the stop of its fragments or thrombus, ESR increase, with multiple input - increase of ALT, AST, alkaline phosphatase, decreased blood pressure, arthritis, vasculitis, nephritis, polyneuropathy, sore muscles, increase body t ° 1 - 2 ° C (within the first 8.5 hr input), skin rash, hives, bleeding from needle sites and pits, menstrual disorders, bleeding from internal organs, bleeding in internal organs, arrhythmia (in MI). cent., diastolic pressure above 100 mmHg. Or diastolic pressure> 110 mmHg. Indications for use drugs: G MI (within the first 12 h); deep Low Back Pain thrombosis; G massive pulmonary embolism, arterial embolism hour occlusion or platelet; trombuvannya hemodializnoho shunt.
ليست هناك تعليقات:
إرسال تعليق